We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
MENQUADFI (Sanofi-Aventis Australia Pty Ltd)
Product name
MENQUADFI
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
183 working days (255)
Active ingredients
meningococcal (Groups A,C,Y,W) polysaccharide tetanus toxoid conjugate vaccine
Registration type
NCE/NBE
Indication
MENQUADFI (solution for injection) is indicated for active immunisation for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.
The use of MENQUADFI should be in accordance with official recommendations.